Semaglutide News and Research

Latest Semaglutide News and Research

New pipeline of drug candidates offers hope for effective MASLD treatments

New pipeline of drug candidates offers hope for effective MASLD treatments

Study links semaglutide to reduced opioid overdose risk in patients with OUD and diabetes

Study links semaglutide to reduced opioid overdose risk in patients with OUD and diabetes

Semaglutide shows promise in treating chronic skin condition in obese patients

Semaglutide shows promise in treating chronic skin condition in obese patients

New guidelines for cardiovascular management in noncardiac surgery released

New guidelines for cardiovascular management in noncardiac surgery released

Medicare coverage for obesity drug raises questions

Medicare coverage for obesity drug raises questions

Research reveals disparities in diabetes drug efficacy for Black populations

Research reveals disparities in diabetes drug efficacy for Black populations

Liraglutide activates key brain circuits to trigger weight loss in obesity

Liraglutide activates key brain circuits to trigger weight loss in obesity

Yoyo dieting alters gut health, driving weight regain and inflammation

Yoyo dieting alters gut health, driving weight regain and inflammation

Bariatric surgery outperforms GLP-1 medications in protecting kidney function

Bariatric surgery outperforms GLP-1 medications in protecting kidney function

Semaglutide vs. liraglutide: One-year weight loss efficacy in obesity and type 2 diabetes

Semaglutide vs. liraglutide: One-year weight loss efficacy in obesity and type 2 diabetes

Real-world data reveals factors associated with long-term weight loss in obesity

Real-world data reveals factors associated with long-term weight loss in obesity

Semaglutide and tirzepatide significantly improve weight loss and glycemic control in type 1 diabetes

Semaglutide and tirzepatide significantly improve weight loss and glycemic control in type 1 diabetes

Obesity medication liraglutide is safe and effective in children aged 6 to <12 years

Obesity medication liraglutide is safe and effective in children aged 6 to <12 years

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

GLP-2 regulates appetite by influencing gut-brain communication and gastrointestinal motility

GLP-2 regulates appetite by influencing gut-brain communication and gastrointestinal motility

Real-world evidence highlights safety profile of tirzepatide in managing type 2 diabetes

Real-world evidence highlights safety profile of tirzepatide in managing type 2 diabetes

Women experience greater weight loss with tirzepatide compared to men

Women experience greater weight loss with tirzepatide compared to men

Obesity medication liraglutide safe and effective in children under 12, research finds

Obesity medication liraglutide safe and effective in children under 12, research finds

Once-a-day oral weight loss drug shows promising results in reducing body weight

Once-a-day oral weight loss drug shows promising results in reducing body weight

GLP-1 receptor agonists show promise in treating substance use disorders

GLP-1 receptor agonists show promise in treating substance use disorders

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.